The following paper is by Tata Consulting Services TCS)researchers. I have not been able to copy and paste from it. It is not that long but if pressed for time reading the Abstract and the conclusion is sufficient.
If you do this you will be reminded or discover that TCS successfully showed that Neuromorphic could be used to monitor cardiac disease in real time in wearables and that they intended to test their findings in AKIDA and Loihi chips.
If we go back to the lifeless body of Grok from today the one thing it did find was that AKIDA was better for these types of applications than Loihi.
While it appears TCS has not yet released its benchmarking results of AKIDA against Loihi the fact that TATA Elxsi partnered with Brainchip to drive adoption of AKIDA in medical applications the following year is probably a pretty good pointer as to which technology won.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)